Muhammad Baluom

Title: Muhammad Baluom: Innovator in Controlled Release Drug Delivery Systems

Introduction

Muhammad Baluom is a notable inventor based in Taibei, IL. He has made significant contributions to the field of drug delivery systems, particularly focusing on controlled release mechanisms. With a total of 2 patents to his name, Baluom's work is paving the way for advancements in pharmaceutical technology.

Latest Patents

Baluom's latest patents include innovative systems for controlled release oral drug delivery. The first patent describes a synchronous drug delivery composition that features a polymeric matrix made from hydrogel blended with a hydrophobic polymer. This erodible matrix allows for the synchronous release of the drug, hydrogel, and agents that enhance intestinal drug absorption or inhibit intestinal drug degradation. The second patent outlines a controlled release drug delivery system that includes a drug susceptible to enzymatic degradation in the intestinal tract. This system utilizes a polymeric matrix that erodes in the gastrointestinal tract, enhancing drug absorption and stability.

Career Highlights

Baluom is currently associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this esteemed institution has allowed him to explore and develop cutting-edge drug delivery technologies. His innovative approaches have garnered attention in the pharmaceutical industry.

Collaborations

Some of Baluom's notable coworkers include Abraham Rubinstein and Michael M Friedman. Their collaborative efforts contribute to the advancement of research and development in drug delivery systems.

Conclusion

Muhammad Baluom's contributions to controlled release drug delivery systems highlight his innovative spirit and dedication to improving pharmaceutical technologies. His patents reflect a commitment to enhancing drug efficacy and patient outcomes.